Cyclopentolate/phenylephrine ophthalmic Drug Interactions
Currently displaying a list of 108 drugs known to interact with cyclopentolate / phenylephrine ophthalmic.
- 8 major drug interactions
- 100 moderate drug interactions
Medications known to interact with cyclopentolate/phenylephrine ophthalmic
Note: Showing generic names only.
A
B
- belladonna
- benzgalantamine
- benztropine
- betaxolol
- betaxolol ophthalmic
- bethanechol
- biperiden
- bisoprolol
- bitolterol
- bupropion
C
D
- demecarium bromide ophthalmic
- deserpidine
- desvenlafaxine
- dicyclomine
- dihydroergotamine
- donepezil
- droxidopa
- duloxetine
E
F
G
H
I
- indacaterol
- iobenguane I 131
- isocarboxazid
- isoetharine
- isoflurophate ophthalmic
- isoniazid
- isoproterenol
K
L
- labetalol
- landiolol
- levalbuterol
- levobetaxolol ophthalmic
- levobunolol ophthalmic
- levomilnacipran
- linezolid
M
- mepenzolate
- metaproterenol
- methscopolamine
- methylene blue
- methylergonovine
- methysergide maleate
- metipranolol ophthalmic
- metoprolol
- midodrine
- milnacipran
N
O
P
- penbutolol
- phenelzine
- phenylephrine
- physostigmine
- physostigmine ophthalmic
- pilocarpine
- pilocarpine ophthalmic
- pindolol
- pirbuterol
- procarbazine
- procyclidine
- propantheline
- propranolol
R
S
T
V
Cyclopentolate/phenylephrine ophthalmic disease interactions
There are 4 disease interactions with cyclopentolate / phenylephrine ophthalmic which include:
More about cyclopentolate / phenylephrine ophthalmic
- cyclopentolate/phenylephrine ophthalmic consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Drug class: mydriatics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.